If as a poster stated the other day about Regal’s shorting thesis……has made me think that a capital raise will be for trials and debt payment
The Heart trials will be very expensive
A capital raise for trials is a company positive but share price negative
We are caught between a rock and a Shorters wet dream
MSB Price at posting:
$1.62 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)